Transplantation Society

Analysis

Transplantation Society is a registered charity in United States, based in Canada. It received its IRS tax-exemption ruling in February 1974, 52 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3).

In the financial year ending December 2023, Transplantation Society reported income of $2.4m and spending of $2.6m, spending 107% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income grew from $2.2m to $2.4m (+10%), an average of +2.4% a year. The sharpest change came in the year to December 2022, when income rose by 111%. Over the whole period it spent 95% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Transplantation Society sits at the 73rd percentile: it is larger than about 73% of them. Against every charity in United States with reported income it ranks in the 87th percentile. Charities of a similar size with the same main cause include Anesthesia Quality Institute ($2.4m), Maine Mobile Health Program Inc ($2.4m) and Creative Growth Inc ($2.4m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 18% and program service revenue 60% of the total. Compensation of current officers, directors and key employees was $128k (4.9% of expenses). Other salaries and wages came to $566k. At year end it held assets of $13.5m against liabilities of $1.6m, net assets of $11.9m.